Strategyx' experience in Managed Markets Segments extends back in time over a decade, to when the impact of this market force was just beginning to be understood. During those ten years, the influence of this segment has waxed and waned, evolved and consolidated – but it remains a critical portal for any drug, therapy or diagnostic launched in the US market. Failure to understand the essence of this portal has limited the success of many market entrants.
Strategyx' Managed Markets experience encompasses:
- Customer segmentation
- Reimbursement and access strategies
- Market opportunity identification
- Account profiling and prioritization
- Market penetration and pull-through
- Advisory boards and focus groups
- Specialty audiences
- Product launch strategies
- Competitive product positioning
Our long-standing presence in this market segment provides unparalleled access to decision-makers whose actions will define the profitability of products and therapeutics across the US. We maintain a continuously updated database of nearly 5,000 key decision-makers in Managed Markets organizations across all geographies. We routinely access this database for primary, qualitative and quantitative input to support multiple project phases:
- Market research interviews
- E-focus groups
- Advisory Boards
- Clinical message testing
Strategyx synthesizes complex market data and qualitative customer input into action-oriented strategies and supporting tactics that help clients develop solid business relationships and product access. For established brands, Strategyx helps clients identify and optimize pull-through opportunities through rigorous regional market assessments, account segmentation and selective targeting.
|
